Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Labia

Showing results (181-190 of 185) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 185 results.
The Journal of Antimicrobial Chemotherapy|July 1, 1995
Analysis of beta-lactamases produced by cephalothin-susceptible Escherichia coli clinical isolates resistant to co-amoxiclav and ticarcillin-clavulanic acid. The CERIB Study GroupH Chardon, S Farzaneh, R Labia, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
A novel class A extended-spectrum beta-lactamase (BES-1) in Serratia marcescens isolated in BrazilR Bonnet, J L Sampaio, C Chanal, et al.
Drugs Under Experimental and Clinical Research|January 1, 1989
Characterization of a plasmid coding for resistance to broad-spectrum cephalosporins in Salmonella typhimuriumA Garbarg-Chenon, H Vu Thien, R Labia, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3C Neuwirth, S Madec, E Siebor, et al.
The Journal of Biological Chemistry|October 3, 1998
X-ray analysis of the NMC-A beta-lactamase at 1.64-A resolution, a class A carbapenemase with broad substrate specificityP Swarén, L Maveyraud, X Raquet, et al.
Pageof 19

Showing results (181-190 of 185) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 185 results.
The Journal of Antimicrobial Chemotherapy|July 1, 1995
Analysis of beta-lactamases produced by cephalothin-susceptible Escherichia coli clinical isolates resistant to co-amoxiclav and ticarcillin-clavulanic acid. The CERIB Study GroupH Chardon, S Farzaneh, R Labia, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
A novel class A extended-spectrum beta-lactamase (BES-1) in Serratia marcescens isolated in BrazilR Bonnet, J L Sampaio, C Chanal, et al.
Drugs Under Experimental and Clinical Research|January 1, 1989
Characterization of a plasmid coding for resistance to broad-spectrum cephalosporins in Salmonella typhimuriumA Garbarg-Chenon, H Vu Thien, R Labia, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3C Neuwirth, S Madec, E Siebor, et al.
The Journal of Biological Chemistry|October 3, 1998
X-ray analysis of the NMC-A beta-lactamase at 1.64-A resolution, a class A carbapenemase with broad substrate specificityP Swarén, L Maveyraud, X Raquet, et al.
Pageof 19